Clinical Study on Skin Lightening With elure(TM) Published in the Journal of Cosmetic Dermatology Shows Significant Superiority in Safety, Effectiveness and Time to Achieve Improved Skin Pigmentation.
Yokneam, Feb. 17 -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today the publication of results from a clinical study evaluating the skin lightening efficacy and safety of its elure(TM) Advanced Skin Lightening product (lignin peroxidase cream) compared with 2% hydroquinone cream. The study, which demonstrated significantly faster and superior skin lightening results with elure, was published in the December 2011 issue of the peer-reviewed Journal of Cosmetic Dermatology. The Journal of Cosmetic Dermatology is the official journal of The International Academy of Cosmetic Dermatology (IACD).
The publication, which is titled "A Randomized and Placebo-Controlled Study to Compare the Skin Lightening, Efficacy, and Safety of Lignin Peroxidase Cream Versus 2% Hydroquinone Cream," is currently available on the journal's online website. The single-center, randomized, double-blind, placebo-controlled study included 51 patients, all of which were Asian women. Patients were randomized to receive day and night applications of elure Advanced Skin Lightening products on one randomly selected side of their face, and either 2% hydroquinone cream or placebo on the other side of their face.
The results from the study demonstrated a statistically significant change from baseline in the melanin index (as measured with optical instrumentation) on skin treated with elure Advanced Skin Lightening products, with a mean reduction of 7.6% (p Syndigate.info an Albawaba.com company
|Printer friendly Cite/link Email Feedback|
|Article Type:||Clinical report|
|Date:||Feb 17, 2012|
|Previous Article:||Horizon Air Orders Two Bombardier Q400 NextGen Airliners.|
|Next Article:||Garuda Indonesia Confirmed as Previously Unidentified Bombardier CRJ1000 NextGen Aircraft Buyer.|